The American Society of Clinical Psychopharmacology (ASCP) will be a virtual conference held from June 1-4, 2021. The ASCP is the premiere meeting each year in the field of psychopharmacology, bringing together representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information.
The theme of this year’s meeting is, “Integrating New and Novel Treatments into Clinical Practice and Education”.
Despite the meeting being virtual in nature, the ASCP has provided plenty of virtual opportunities for attendees to help construct a virtual recipe book by submitting their favorite recipes, and participate in a virtual exercise challenge in which attendees can sign up to run in the annual Fun Run.
Beginning on June 1, 2021, the ASCP Annual Meeting will begin with an opening and awards ceremony as well as the presentation of the ASCP Lifetime Awardee. The first day of the conference also boasts a virtual happy hour.
On Wednesday, June 2, attendees can start their day by participating in the Fun Run followed by Poster Sessions and Individual Research Reports. After a quick break, attendees can join a Psychopharmacology Updates Session.
Thursday, June 3, will be poster and plenary sessions as well as the Keynote address given by Susan Kornstein, M.D., Luca Pani, M.D., Edward Nunes, M.D., Sarah Lisanby, M.D., and Samantha Meltzer-Brody, M.D., M.P.H.. There will also be an Inclusivity Session held on Thursday, titled, “ASCP Discussion of Strategies For Becoming a More Inclusive Organization.”
The last day of the meeting, June 4, will offer a wrap-up plenary session and a Federal Agency Updates Plenary. The meeting will end with additional panel discussions.
For a full breakdown of each Plenary and what to expect during each discussion, the ASCP has provided an in-depth portal to create your own account, make a calendar, save important dates, filter the types of sessions to attend, and browse networking opportunities. To view the portal, click here.
Attendees at the meeting have ample opportunity for CME/CE credit. The educational objectives of the meeting include the following:
- Implementation of clinical trials design, methodology, diagnosis, clinical assessment, patient ascertainment, and recruitment.
- Measurement of functional outcomes for psychosocial and biomedical intervention research across a range of disorders and diverse populations.
- Utilization of new technologies that can advance the development of new interventions.
- Translation of new findings/research into knowledge or action to improve practices.
The accreditation opportunities come from the following organizations:
- Physicians (ACCME)
- Nurses (ANCC)
- Pharmacists (ACPE)
- Psychologists (APA)
- New York Board for Psychology (NY PSY)
After the meeting, participants have the opportunity to complete a Meeting Evaluation survey. For any participants wishing to gain CME/CE credit, they must complete the survey. Participants’ input on each meeting helps to shape the agenda for future meetings and guide the ASCP on important meeting decisions.
To submit an abstract, authors can make an account within the ASCP virtual platform. The Program Committee welcomes submissions from the U.S. as well as international proposals and strongly encourages the composition of panels and workshops that include women, under-represented minorities, and early career researchers, investigators, and clinicians.
The Committee has detailed submission guidelines, which can be found here.
To register for ASCP 2021, attendees have until June 4, 2021. The meeting is open to members, non-member clinicians, government officials, students, and additional healthcare personnel. Registration descriptions are as follows:
- ASCP Member:
- ASCP Full Membership is limited to physician practitioners of psychopharmacology (M.D. or D.O.) and holders of other doctoral degrees who are investigators of clinical psychopharmacology or pharmacology.
- Associate Membership is offered to clinicians or clinician/researchers (non-M.D.; non-D.O.; non-Ph.D.) in the field.
- Academic / Government is for those attendees who are employed by an academic institution or a government agency.
- Clinician is for attendees who are practicing clinicians in a private practice or not-for-profit organization.
- Industry is for attendees who are part-time or full-time employees with a for-profit research organization.
- Fully Retired is for attendees that do not see patients (other than as an unpaid volunteer) and have no professional income from any source (including consulting fees or honoraria from companies, etc.).
- New Investigator Alumni is for past New Investigator Awardees.
- Trainee and Student registration is for those attendees who are in a training position (not a full time permanent position). To qualify for the Trainee / Student rate, the attendee MUST submit a letter from their training director or department head verifying that they are in an approved psychiatric residency program with a specified end date.
Full registration details can be found here.